Patent details

EP1420790 Title: USE OF BIBN4096 IN COMBINATION WITH OTHER ANTIMIGRAINE DRUGS FOR THE TREATMENT OF MIGRAINE

Basic Information

Publication number:
EP1420790
PCT Application Number:
PCT/EP/2002/008993
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027947720
PCT Publication Number:
WO/2003/015787
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF BIBN4096 IN COMBINATION WITH OTHER ANTIMIGRAINE DRUGS FOR THE TREATMENT OF MIGRAINE
French Title of Invention:
UTILISATION DE BIBN4096 EN COMBINAISON AVEC D'AUTRES MEDICAMENTS CONTRE LA MIGRAINE POUR LE TRAITEMENT DE LA MIGRAINE
German Title of Invention:
VERWENDUNG VON BIBN4096 IN KOMBINATION MIT ANDEREN MIGRÄNEMITTELN ZUR BEHANDLUNG VON MIGRÄNE
SPC Number:

Dates

Filing date:
10/08/2002
Grant date:
21/09/2005
EP Publication Date:
21/09/2005
PCT Publication Date:
27/02/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2004
EP B1 Publication Date:
21/09/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/08/2006
Expiration date:
10/08/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/08/2002
 
 

Name:
Boehringer Ingelheim Pharma GmbH & Co.KG
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
RUDOLF Klaus
Address:
Germany (DE)

2

Name:
EBERLEIN Wolfgang
Address:
Germany (DE)

3

Name:
DOODS Henri
Address:
Germany (DE)

Priority

Priority Number:
10139410
Priority Date:
17/08/2001
Priority Country:
Germany (DE)

Classification

Main IPC Class:
A61K 31/517;
Filing date Document type Number of pages